Menu

Blog

Page 9152

Mar 31, 2017

Solar-Powered Graphene Skin Enables Prosthetics to Feel

Posted by in categories: biotech/medical, cyborgs, robotics/AI, sustainability

The team tested their device on a prosthetic hand. When the skin patches on the skin were enabled, the prosthetic could touch and grab soft objects like a normal hand. But when the skin was not turned on, the hand crushed the objects.

The skin requires just 20 nanowatts of power per square centimeter, according to the paper. Right now, the energy captured by the photovoltaic cells has to be used immediately, but the team has another prototype in development that includes flexible supercapacitors to store excess energy.

Continue reading “Solar-Powered Graphene Skin Enables Prosthetics to Feel” »

Mar 31, 2017

Research Suggests Periodic Fasting Might Reverse Type 1 Diabetes

Posted by in category: biotech/medical

Fasting might help T1 diabetics according to new research.


Periodic fasting has long been demonstrated to have beneficial effects on autoimmune disorders, cancer prevention and treatments, cardiovascular disease and a myriad of other ailments. This most recent paper by Cheng et al. may add the treatment of Type 1 diabetes to that list[1]. If successful in humans it has the potential to reverse some or most of the loss of insulin producing cells within the pancreas. Just as remarkable, the treatment itself is relatively straightforward, consisting of a regimented protocol of periodic fasting-like conditions.

Generally speaking, Type 1 diabetes results from an autoimmune mediated depletion of insulin secreting pancreatic beta islet cells. In contrast, Type 2 results from lower cellular sensitivity to insulin. Type 2 is primarily caused by environmental factors such as poor diet.

Continue reading “Research Suggests Periodic Fasting Might Reverse Type 1 Diabetes” »

Mar 31, 2017

SRI International Receives U.S. FDA Clearance for Investigational New Drug Application Evaluating Novel Oral Treatment to Combat Radiation Exposure

Posted by in category: biotech/medical

Creating oral formulations of intravenous (IV) medication is a daunting challenge. Scientists at SRI Biosciences are using advanced formulation tools and experience to overcome the challenges, with the goal of developing drugs that could easily be distributed to people if needed.

Read more

Mar 31, 2017

A.I. Versus M.D

Posted by in category: robotics/AI

What happens when diagnosis is automated?

Read more

Mar 31, 2017

How automation and artificial intelligence could transform backup software

Posted by in category: robotics/AI

HAL-like control of data backups may be science fiction, but some of the basic concepts are not so far removed from reality. The person in charge of strategy for Commvault is intrigued by these ideas.

Read more

Mar 31, 2017

Chinese internet giant Tencent buys 5% of Tesla

Posted by in category: internet

Tencent, Asia’s second highest valued tech firm, has bought a five percent share in Tesla. According to a filing, the Chinese firm scooped up 8,167,for around $1.7 billion to become one of Tesla’s largest shareholders.

The news itself sent Tesla’s share price up three percent in pre-market trading. The purchase was arranged on March 17, and those now-Tencent-owned shares are worth around $2.2 billion at current market value.

Tencent is a prolific investor. It holds equity in Snap, this year’s hot tech IPO, among others following an early investment. While that interest in messaging makes sense since Tencent’s operates China’s dominant chat app — WeChat — it isn’t immediately clear whether the Tesla investment has strategic undertones. An alliance with Tencent could significantly boost Tesla’s efforts in China, which is already impressive. Chinese sales accounted for 15 percent of Tesla’s $7 billion revenue last year.

Continue reading “Chinese internet giant Tencent buys 5% of Tesla” »

Mar 31, 2017

Are we really making progress towards human-level artificial intelligence?

Posted by in category: robotics/AI

Intelligent Machines

Is artificial intelligence stuck in A rut?

The former director of Uber’s AI lab says the field is in danger of losing sight of its long-term goals.

Continue reading “Are we really making progress towards human-level artificial intelligence?” »

Mar 31, 2017

Andrew Ng is gone, but Baidu is still counting on AI to fix its business woes

Posted by in categories: business, robotics/AI

The Chinese search giant lost the star leader of its AI lab last week, but the technology remains an essential long-term focus.

  • by.

    Yiting Sun

  • March 30, 2017

Read more

Mar 31, 2017

Google Chases General Intelligence With New AI That Has a Memory

Posted by in category: robotics/AI

For a mind to be capable of tackling anything, it has to have a memory.

Humans are exceptionally good at transferring old skills to new problems. Machines, despite all their recent wins against humans, aren’t. This is partly due to how they’re trained: artificial neural networks like Google’s DeepMind learn to master a singular task and call it quits. To learn a new task, it has to reset, wiping out previous memories and starting again from scratch.

This phenomenon, quite aptly dubbed “catastrophic forgetting,” condemns our AIs to be one-trick ponies.

Continue reading “Google Chases General Intelligence With New AI That Has a Memory” »

Mar 31, 2017

IBM Watson: The Ingredient Brand Helping Inform The Purposeful Business Of Tomorrow

Posted by in categories: business, robotics/AI

We will be able to embed storytelling directly into business strategy development, tell meaningful and memorable stories that truly connect with employees and customers, craft moments that are personalized and frictionless, and as a bonus, have the ability to harness Watson to optimize distribution across channel, demo and geography.

This is particularly resonant as I believe that just as the last twenty years mandated that every organization strive to be a technology company, the next twenty will command every winning corporation to be a content or media brand. In my view, Watson and AI will be the ingredient brand catalyzing tomorrow’s innovation at leading corporations in many ways; but media for certain will be top of the list, as AI assists them in becoming the top content studios of the future. Smaller businesses can scale these ideas using Watson as well as compelling content creation becomes an increasingly important driver of business strategy.

Tomorrow’s business success stories will be fueled by AI that extends beyond the CTO and areas of pure technology and infrastructure, to the CMO and areas ranging from culture to communication to creativity. The winning formula of the future as articulated by IBM will be creativity + technology = meaningful engagement, and the ability to activate purposeful change.

Continue reading “IBM Watson: The Ingredient Brand Helping Inform The Purposeful Business Of Tomorrow” »